The author made an organizational and legal, clinical and pharmacological study of the latest International Classification of Diseases (ICD-11) concerning its changes compared to the ICD-10. Particular attention was paid to new ways of marking of disease codes and new functions of the ICD-11. Novel structure based on cluster coding, which was implemented into the new revision was mentioned, which allows to connect the main diagnostic codes with advanced clinical indicators. Author found that for the first time, the new revision has become a fully electronic publication that provides access to more than 17,000 diagnostic categories that contain more than hundred thousand of terms of the medical diagnostic index. The new ICD-11 concept of linearization for the national needs of each country was taken into account, which will save budget expenditures for the future. In the new edition of the ICD-11, for the first time, gambling addiction is classified as a mental disorder – behavioral addiction to online and offline gambling. The list of ICD-11 short stories also includes the classification of the following: chronic pain, burnout, stroke, sexual health, post-traumatic stress disorder, allergies, alternative medicine, etc. It is a more powerful health information system based on a formal ontology, designed to integrate information technology into modern infrastructures. A comparison with the ICD-10 on mental and behavioral disorders due to the use of psychoactive substances was made. The ICD-11 has been identified as having a more comprehensive list of disease diagnosis codes, and in the ICD-10 the section on mental and behavioral disorders due to substance use has eleven core codes. Indicated the prospects of using of the ICD-11 in medical practice.
19 October 2022 in SSP Modern Pharmacy and Medicine
The COVID-19 pandemic has strained the healthcare system. It is important to consider forensic and pharmaceutical risks in the organization of vaccination practices and pharmacotherapy of covid, post-covid and long-covid disorders. Scientific sources on the clinical characteristics of SARS-CoV-2, COVID-19 have been systematized. The standards of vaccination practice (immunization, vaccination) of different age categories of the population in Ukraine, England, USA, Belgium, Greece, Japan, and Portugal were analyzed. Proven that the organization of pharmacotherapy schemes is difficult due to the presence of mixed infections, comorbid and complicated forms of diseases, the formation of virus resistance to drugs, and the development of secondary immunological insufficiency. The risks of pharmacotherapy with regard to mortality in patients with COVID-19 due to the development of severe lung lesions and systemic multiorgan pathology are indicated. Schemes of combined pharmacotherapy including antiviral, anti-inflammatory drugs, glucocorticosteroids, genetically engineered biological drugs and "targeted" basic anti-inflammatory drugs were analyzed. The theoretical prerequisites for "repositioning" (drug repurposing) for the treatment of COVID-19 and ego complications are indicated. New directions of anti-inflammatory pharmacotherapy of COVID-19 Janus kinase with a range of anti-inflammatory and antiviral effects were noted. Emphasis was placed on the importance of informing health care professionals about forensic pharmaceutical risks in pharmacotherapy and vaccination practices. The relevance of legal support for medical activity in the conditions of a pandemic was noted. Further research is ongoing.
The article presents the results of the research for the new challenges of today regarding the incidence of monkeypox virus using organizational and legal, clinical and pharmacological approaches to analyze epidemiology, risks, symptoms, vaccination opportunities, recommendations for detection, pharmacotherapy and prevention. Complex experimental organizational and legal, clinical a n d pharmacological study was conducted. The research was conducted on the basis of the disciplines of healthcare organization, pharmacy organization and management, forensic pharmacy, clinical pharmacy, management for different groups of patients and was based on the principles of evidence-based medicine, evidence-based pharmacy. Issues of epidemiology, risks, symptoms, vaccination of monkeypox disease were studied. Recommendations of the WHO and scientific circles concerning the effectiveness of detection, pharmacotherapy, and prevention of monkeypox were analyzed.
The article presents the results of the search for innovative technologies in a multidisciplinary study of the availability of COVID-19 vaccines of any type in the world. In the context of the coronavirus pandemic, multidisciplinary health research brings together the interdisciplinary links of scientists from around the world in medicine, pharmacy, law, economics on good medical practice, pharmaceutical provision and vaccination availability for all contingent of patients and postcovid health disorders. The aim of the research was to search for innovative technologies for the study of medically approved vaccines against COVID-19 in countries around the world using a multidisciplinary and integrated approach in the application of traditional and new methods of analysis. Content analysis was performed according to the range of licenses, permits for medical use and manufacturers by grouping them using the Sturgess formula, followed by construction of a discrete series of variations and distribution polygon. The results show satisfactory availability of vaccines against COVID-19 of any type. Doctors have a choice of appropriate vaccines and the manufacturer that corresponds to the social personalized vaccination taking into account the individual characteristics of patients.
The development of health care and the pharmaceutical industry is based on the principles of the Constitution of Ukraine, the fundamental principles of the European Union, the basics of medical and pharmaceutical law. The Ministry of Health of Ukraine and the National Health Service of Ukraine are responsible for the protection of human rights and freedoms, human life and health, patients, and the nation’s gene pool, as well as privileged categories of citizens. State institutions on the basis of the Constitution of Ukraine, Laws of Ukraine, regulations of Ukraine and Resolutions of the Cabinet of Ministers of Ukraine during the implementation of the "Program of Medical Guarantees" for 2022 decide organizational and legal, medical and pharmaceutical, social and economic issues of the program of state guarantees of medical care population in 2022 according to ICD-11.
14 October 2021 in SSP Modern Pharmacy and Medicine
An interdisciplinary pharmacoeconomic study of pharmacotherapy for the relief of alcoholic dependence on the basis of experimental clinical and pharmacological, organizational, legal and marketing studies. The scheme of basic pharmacotherapy of relief of drunken forms of alcohol dependence developed by the authors for the interdisciplinary study was used. Thirteen international nonproprietary names of drugs from Ukrainian (92.3%) and foreign (7.7%) manufacturers were selected. It was established that for pharmacotherapy of support of relief of drunken forms of alcohol dependence tablets occupy 23,1% of appointments of doctors, solutions – 76,9%. The scheme of pharmacotherapy in the relief of intoxicated forms of alcohol dependence includes 38.5% of international nonproprietary names of drugs with ATC code "A" - drugs that affect the digestive system and metabolism; 30.7% with ATC code "B" - drugs that affect the blood system and hematopoiesis; 15.4% with ATC codes of classification "C" – drugs that affect the cardiovascular system and "N" – drugs that affect the nervous system. Nomenclature and legal analysis showed that 92.3% of the studied drugs belong to prescription nomenclature and legal group; the share of OTC drugs is 7.69% (international nonproprietary name Antral).